COR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Cencora Inc (COR) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company demonstrates strong financial performance, positive analyst sentiment, and hedge fund interest, making it a solid choice for long-term growth. While the stock has seen a slight recent decline, its fundamentals and growth prospects outweigh short-term fluctuations.
The technical indicators for COR are mixed but lean slightly bullish. The MACD histogram is above 0 and positively contracting, indicating potential upward momentum. The RSI is neutral at 44.142, suggesting no overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading near its pivot level of 353.165, with support at 335.257 and resistance at 371.073.
Hedge funds are significantly increasing their holdings, with a 2472.49% increase in buying over the last quarter.
Analysts are overwhelmingly positive, with multiple upgrades and price target increases, citing strong growth potential and strategic acquisitions.
The company has cleared major risks related to Walgreens and government drug pricing, paving the way for accelerated growth.
Strong Q1 2026 financial performance, including YoY revenue growth of 5.45% and net income growth of 14.54%.
The stock experienced a -4.00% regular market decline, which could indicate short-term selling pressure.
Options data shows a higher put volume compared to call volume (Put-Call Ratio=1.29), suggesting bearish sentiment in the short term.
The stock has a historical pattern of slight declines in the next week (-0.7%) and month (-4.54%).
Cencora's Q1 2026 financials are strong, with revenue increasing by 5.45% YoY to $85.93 billion, net income up 14.54% YoY to $559.65 million, EPS up 14.80% YoY to $2.87, and gross margin improving by 17.63% YoY to 3.27%. These figures indicate robust growth and profitability.
Analysts are highly positive on Cencora, with multiple firms upgrading their ratings and raising price targets. Recent upgrades include Wells Fargo ($429), JPMorgan ($419), and Jefferies ($440). Analysts highlight the company's strategic acquisitions, international turnaround, and cleared risks as key drivers for future growth.
